Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancer. (Q51738252)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Vanessa Gauttier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Jean-Paul Judor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Valentin Le Guen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Jeannette Cany

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Nicolas Ferry

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

English

0 references

publication date

23 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

17 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

2857-2867

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24789574%20AND%20SRC:MED&resulttype=core&format=json

Hepatocellular carcinoma--epidemiological trends and risk factors

17 March 2020

cites work

1 reference

Novel advancements in the management of hepatocellular carcinoma in 2008.

21 January 2018

1 reference

Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections

21 January 2018

1 reference

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma

21 January 2018

1 reference

Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma

21 January 2018

1 reference

Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival

21 January 2018

1 reference

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

21 January 2018

1 reference

Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies.

21 January 2018

1 reference

4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses

21 January 2018

1 reference

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion

21 January 2018

1 reference

CD137 agonist antibody prevents cancer recurrence: contribution of CD137 on both hematopoietic and nonhematopoietic cells

21 January 2018

1 reference

DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination

21 January 2018

1 reference

A transgenic mouse with beta-Galactosidase as a fetal liver self-antigen for immunotherapy studies.

21 January 2018

1 reference

Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity

21 January 2018

1 reference

Immunostimulatory monoclonal antibodies for cancer therapy

21 January 2018

1 reference

Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma

21 January 2018

1 reference

Alternative activation of macrophages

21 January 2018

1 reference

High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection.

21 January 2018

1 reference

Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection.

21 January 2018

1 reference

Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients

21 January 2018

1 reference

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

21 January 2018

1 reference

Experimental models of hepatocellular carcinoma

21 January 2018

1 reference

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer

21 January 2018

1 reference

Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.

21 January 2018

1 reference

Eradication of established tumors in mice by a combination antibody-based therapy

21 January 2018

1 reference

Role of 4-1BB:4-1BB ligand in cancer immunotherapy.

21 January 2018

1 reference

Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma

21 January 2018

1 reference

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

21 January 2018

1 reference

Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies

21 January 2018

1 reference

Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ

21 January 2018

1 reference